Peto's Paradox - Why Don't Elephants Get Cancer?

The Paradox

Elephants have 100× more cells than humans, and each cell division is a chance for cancer-causing mutations. By this logic, virtually ALL elephants should die of cancer. But only ~5% do—compared to ~20% of humans! The more cells you have, the LESS cancer you get? That's backwards!

🔬 Species Comparison

📊 Expected vs Actual Cancer Rates

🧬 The p53 Solution

In 2015, Joshua Schiffman discovered elephants have 20 copies of the p53 tumor suppressor gene. Humans have just 2!

Human p53 Genes

🧬🧬

Elephant p53 Genes

How It Works

When DNA damage is detected, p53 triggers cell death (apoptosis). Elephant cells are 2× more likely to self-destruct rather than become cancerous. More p53 = more checkpoints = fewer mutations survive.

⚡ Mutation Simulation

Watch cells divide and mutate. Larger animals have more divisions = more mutation opportunities!

Mutations detected: 0

📅 Discovery Timeline

1977

Richard Peto first describes the paradox: larger animals don't have proportionally higher cancer rates despite more cells.

2015

Schiffman et al. discover elephants have 20 copies of p53. Elephant cells are 2× more likely to undergo apoptosis after DNA damage.

2015

Lynch et al. independently confirm findings. Show p53 copies were duplicated in elephant ancestors ~25-30 million years ago.

2018

Sulak et al. identify LIF6, a "zombie gene" in elephants that was reactivated to enhance cancer resistance.

🎯 Key Insight

Evolution solved the cancer problem for large animals! Natural selection favored individuals with better tumor suppression—because without it, they'd die before reproducing. The larger the animal, the stronger the evolutionary pressure for anti-cancer mechanisms. Cancer is a constraint on body size.